2020.11.09

Notification of Voluntary Recall for Overseas Pharmaceutical Drug “SALONPAS_®” (2 Patches)

2020.10.08

FY02/2021 Q2 Results Earnings Release Presentation

2020.10.07

Notification of the commencement of the Phase III clinical study of HP-5070 in Japan (primary palmar hyperhidrosis treatment drug)

2020.09.10

Notification of application for manufacturing and marketing approval of the additional indications of cancer pain relief for pediatric patients of Fentos_®Tape (Transdermal, pain management patch,Development code: HFT-290) in Japan

2020.07.29

Notice Regarding Resignation of Board of Director and Post After Resignation